Vimarsana
Biggest News Aggregation in the World

Page 11 - Entrypoint Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Entrypoint Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Entrypoint Capital Today - Breaking & Trending Today

Sinclair, Inc. (NASDAQ:SBGI) Given Average Recommendation of "Hold" by Analysts - Vimarsana News

Sinclair, Inc. (NASDAQ:SBGI) Given Average Recommendation of "Hold" by Analysts

Sinclair, Inc. (NASDAQ:SBGI – Get Free Report) has earned an average recommendation of “Hold” from the five brokerages that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. The average twelve-month […]

Source: wkrb13.com
RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Rating of "Hold" from Analysts - Vimarsana News

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Rating of "Hold" from Analysts

RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has received a consensus recommendation of “Hold” from the thirteen analysts that are currently covering the company, Marketbeat Ratings reports. Nine analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price among […]

Source: wkrb13.com
RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Rating of "Hold" from Brokerages - Vimarsana News

RAPT Therapeutics, Inc. (NASDAQ:RAPT) Receives Average Rating of "Hold" from Brokerages

RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has earned an average rating of “Hold” from the thirteen ratings firms that are currently covering the stock, Marketbeat.com reports. Nine equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective […]

Cytokinetics (NASDAQ:CYTK) PT Lowered to $78.00 at JMP Securities - Vimarsana News

Cytokinetics (NASDAQ:CYTK) PT Lowered to $78.00 at JMP Securities

Cytokinetics (NASDAQ:CYTK – Free Report) had its price target decreased by JMP Securities from $106.00 to $78.00 in a research note issued to investors on Tuesday, Benzinga reports. JMP Securities currently has a market outperform rating on the biopharmaceutical company’s stock. CYTK has been the subject of a number of other reports. Mizuho dropped their […]

Kratos Defense & Security Solutions (NASDAQ:KTOS) Price Target Raised to $23.00 - Vimarsana News

Kratos Defense & Security Solutions (NASDAQ:KTOS) Price Target Raised to $23.00

Kratos Defense & Security Solutions (NASDAQ:KTOS – Free Report) had its price target increased by JPMorgan Chase & Co. from $20.00 to $23.00 in a report published on Tuesday, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the aerospace company’s stock. Several other equities research analysts also recently issued reports on […]